Zimmer Biomet Holdings (ZBH) 125.59 $ZBH
2016 INVESTIndiana Equity Conference Announces Corporate Presentation Lineup
BusinessWire - Tue Jul 12, 10:00AM CDT
INVESTIndiana, an equity conference that highlights the performance of Indiana public companies, today announced a presentation lineup that features Indiana's top health sciences companies as well as leaders in the banking, energy, high-tech and manufacturing sectors.
ESCA: 10.09 (+0.27), ININ: 43.96 (+1.24), ZBH: 125.59 (+0.51), GABC: 34.26 (+1.20), KBAL: 11.84 (+0.13), HBNC: 26.38 (+0.31), LLY: 79.71 (+0.57), LKFN: 48.34 (+1.29), SRCE: 33.39 (+0.68), ONB: 12.97 (+0.31), ECYT: 3.24 (+0.05), NI: 25.96 (-0.11), INBK: 24.63 (+0.25), BASI: 1.20 (-0.03), MFSF: 28.80 (+0.44)
Zimmer Biomet Announces Live Audio Webcast and Conference Call of Second Quarter 2016 Results
PR Newswire - Mon Jul 11, 3:01PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter 2016 sales and earnings conference call will be broadcast live over the Internet on Thursday, July 28, 2016, at 8 a.m. Eastern Time. A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call.
ZBH: 125.59 (+0.51)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 42.62 (+0.50), JNJ: 123.07 (+0.14), ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03), MDT: 89.00 (+0.49), TMO: 154.70 (+2.36), STJ: 81.16 (+0.49), HTWR: 57.65 (+0.18), XRAY: 63.55 (-0.19), NUVA: 61.11 (-0.46), FEIC: 106.71 (-0.08)
Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.61 (-0.16), ICUI: 115.98 (+0.24), ZBH: 125.59 (+0.51), NUVA: 61.11 (-0.46)
Medical Appliances & Equipment Equities Technical Coverage -- Zimmer Biomet Holdings, Wright Medical Group, The Spectranetics, and Prestige Brands Holdings
PR Newswire - Fri Jul 01, 7:25AM CDT
On Thursday, June 30, 2016, the NASDAQ Composite ended the trading session at 4,842.67, up 1.33%; the Dow Jones Industrial Average advanced 1.33%, to finish at 17,929.99; and the S&P 500 closed at 2,098.86, up 1.36%. The gains were broad based as all the sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corporation (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Learn more about these stocks by accessing their free trade alerts at:
SPNC: 20.69 (+0.33), ZBH: 125.59 (+0.51), WMGI: 20.70 (+0.46), PBH: 56.83 (+0.74), WMGIZ: 1.33 (+0.03)
Zimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System
PR Newswire - Mon Jun 27, 3:30PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the 40th anniversary of the Oxford® Partial Knee System, the most widely used and clinically proven1 partial knee replacement system in the world. A partial knee replacement is a treatment for osteoarthritis (OA) in which one of the knee's three compartments is replaced, whereas with total knee replacement, all three of the knee's compartments are replaced. Studies have shown partial knee replacement patients have better range of motion2-3, shorter hospital stays with a rapid recovery protocol2, and fewer and less severe complications4, compared to total knee replacement patients.
ZBH: 125.59 (+0.51)
Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
PR Newswire - Thu Jun 16, 3:30PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements to its OSS(TM) Orthopedic Salvage System, a comprehensive set of joint reconstruction prostheses designed to treat patients suffering from bone loss due to tumor resection, ligamentous deficiencies, orthopaedic trauma or patients who have undergone multiple knee and hip revision arthroplasties.
ZBH: 125.59 (+0.51)
LDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.
PR Newswire - Wed Jun 15, 10:18AM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ:LDRH) for potential breaches of fiduciary duties in connection with the sale of the Company to Zimmer Biomet Holdings, Inc. for approximately $1.0 billion.
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
PR Newswire - Thu Jun 09, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
PR Newswire - Wed Jun 08, 7:14PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 23.61 (-0.16), ICUI: 115.98 (+0.24), ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
ACCESSWIRE - Tue Jun 07, 10:19AM CDT
NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Tue Jun 07, 9:28AM CDT
Rigrodsky & Long, P.A.:
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer buying LDR for $1 billion
AP - Tue Jun 07, 8:04AM CDT
NEW YORK (AP) — Zimmer Biomet will spend $1 billion to acquire medical device maker buy LDR Holding Corp., strengthening its position in the spine disorder surgical technology business.
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 07, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
GlobeNewswire - Tue Jun 07, 6:05AM CDT
-- Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine Market
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
PR Newswire - Tue Jun 07, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.
ZMH: 113.56 (+0.29), ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
How are These Healthcare Stocks Faring? - Zimmer Biomet, Wright Medical, Spectranetics and Prestige Brands
PR Newswire - Fri Jun 03, 7:00AM CDT
In today's pre-market coverage, ActiveWallSt.com has these four Medical Appliances and Equipment stocks lined up for investors to review: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corp. (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Register now to access these stocks' trade alerts by clicking on the following link:
SPNC: 20.69 (+0.33), ZBH: 125.59 (+0.51), WMGI: 20.70 (+0.46), PBH: 56.83 (+0.74), WMGIZ: 1.33 (+0.03)
Zimmer Biomet: Strong Q1, Integration Synergy Continues
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:39AM CDT
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.61 (-0.16), ICUI: 115.98 (+0.24), ZBH: 125.59 (+0.51), NUVA: 61.11 (-0.46)
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016
PR Newswire - Mon May 23, 6:30AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2016.
ZBH: 125.59 (+0.51)
2016 INVESTIndiana Equity Conference Announces Corporate Presentation Lineup
BusinessWire - Tue Jul 12, 10:00AM CDT
INVESTIndiana, an equity conference that highlights the performance of Indiana public companies, today announced a presentation lineup that features Indiana's top health sciences companies as well as leaders in the banking, energy, high-tech and manufacturing sectors.
ESCA: 10.09 (+0.27), ININ: 43.96 (+1.24), ZBH: 125.59 (+0.51), GABC: 34.26 (+1.20), KBAL: 11.84 (+0.13), HBNC: 26.38 (+0.31), LLY: 79.71 (+0.57), LKFN: 48.34 (+1.29), SRCE: 33.39 (+0.68), ONB: 12.97 (+0.31), ECYT: 3.24 (+0.05), NI: 25.96 (-0.11), INBK: 24.63 (+0.25), BASI: 1.20 (-0.03), MFSF: 28.80 (+0.44)
Zimmer Biomet Announces Live Audio Webcast and Conference Call of Second Quarter 2016 Results
PR Newswire - Mon Jul 11, 3:01PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter 2016 sales and earnings conference call will be broadcast live over the Internet on Thursday, July 28, 2016, at 8 a.m. Eastern Time. A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call.
ZBH: 125.59 (+0.51)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 42.62 (+0.50), JNJ: 123.07 (+0.14), ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03), MDT: 89.00 (+0.49), TMO: 154.70 (+2.36), STJ: 81.16 (+0.49), HTWR: 57.65 (+0.18), XRAY: 63.55 (-0.19), NUVA: 61.11 (-0.46), FEIC: 106.71 (-0.08)
Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.61 (-0.16), ICUI: 115.98 (+0.24), ZBH: 125.59 (+0.51), NUVA: 61.11 (-0.46)
Medical Appliances & Equipment Equities Technical Coverage -- Zimmer Biomet Holdings, Wright Medical Group, The Spectranetics, and Prestige Brands Holdings
PR Newswire - Fri Jul 01, 7:25AM CDT
On Thursday, June 30, 2016, the NASDAQ Composite ended the trading session at 4,842.67, up 1.33%; the Dow Jones Industrial Average advanced 1.33%, to finish at 17,929.99; and the S&P 500 closed at 2,098.86, up 1.36%. The gains were broad based as all the sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corporation (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Learn more about these stocks by accessing their free trade alerts at:
SPNC: 20.69 (+0.33), ZBH: 125.59 (+0.51), WMGI: 20.70 (+0.46), PBH: 56.83 (+0.74), WMGIZ: 1.33 (+0.03)
Zimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System
PR Newswire - Mon Jun 27, 3:30PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the 40th anniversary of the Oxford® Partial Knee System, the most widely used and clinically proven1 partial knee replacement system in the world. A partial knee replacement is a treatment for osteoarthritis (OA) in which one of the knee's three compartments is replaced, whereas with total knee replacement, all three of the knee's compartments are replaced. Studies have shown partial knee replacement patients have better range of motion2-3, shorter hospital stays with a rapid recovery protocol2, and fewer and less severe complications4, compared to total knee replacement patients.
ZBH: 125.59 (+0.51)
Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
PR Newswire - Thu Jun 16, 3:30PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements to its OSS(TM) Orthopedic Salvage System, a comprehensive set of joint reconstruction prostheses designed to treat patients suffering from bone loss due to tumor resection, ligamentous deficiencies, orthopaedic trauma or patients who have undergone multiple knee and hip revision arthroplasties.
ZBH: 125.59 (+0.51)
LDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.
PR Newswire - Wed Jun 15, 10:18AM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ:LDRH) for potential breaches of fiduciary duties in connection with the sale of the Company to Zimmer Biomet Holdings, Inc. for approximately $1.0 billion. ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
PR Newswire - Thu Jun 09, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
PR Newswire - Wed Jun 08, 7:14PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 23.61 (-0.16), ICUI: 115.98 (+0.24), ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
ACCESSWIRE - Tue Jun 07, 10:19AM CDT
NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Tue Jun 07, 9:28AM CDT
Rigrodsky & Long, P.A.:
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer buying LDR for $1 billion
AP - Tue Jun 07, 8:04AM CDT
NEW YORK (AP) — Zimmer Biomet will spend $1 billion to acquire medical device maker buy LDR Holding Corp., strengthening its position in the spine disorder surgical technology business.
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 07, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
GlobeNewswire - Tue Jun 07, 6:05AM CDT
-- Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine Market
ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
PR Newswire - Tue Jun 07, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.
ZMH: 113.56 (+0.29), ZBH: 125.59 (+0.51), LDRH: 36.97 (-0.03)
How are These Healthcare Stocks Faring? - Zimmer Biomet, Wright Medical, Spectranetics and Prestige Brands
PR Newswire - Fri Jun 03, 7:00AM CDT
In today's pre-market coverage, ActiveWallSt.com has these four Medical Appliances and Equipment stocks lined up for investors to review: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corp. (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Register now to access these stocks' trade alerts by clicking on the following link:
SPNC: 20.69 (+0.33), ZBH: 125.59 (+0.51), WMGI: 20.70 (+0.46), PBH: 56.83 (+0.74), WMGIZ: 1.33 (+0.03)
Zimmer Biomet: Strong Q1, Integration Synergy Continues
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:39AM CDT
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.61 (-0.16), ICUI: 115.98 (+0.24), ZBH: 125.59 (+0.51), NUVA: 61.11 (-0.46)
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016
PR Newswire - Mon May 23, 6:30AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2016.
ZBH: 125.59 (+0.51)
